Discontinuation report AUBAGIO

Last updated on 2024-05-02 History
Report ID 226847
Drug Identification Number 02416328
Brand name AUBAGIO
Common or Proper name teriflunomide
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) TERIFLUNOMIDE
Strength(s) 14MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 14 mg
ATC code L04AA
ATC description IMMUNOSUPPRESSANTS
Reason for discontinuation Other (Please describe in comments)
Anticipated discontinuation date 2024-10-31
Actual discontinuation date
Remaining supply date
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Company business decision
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2024-05-02 French Compare
v1 2024-05-02 English Compare

Showing 1 to 2 of 2